Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): Early results from a multicenter phase I trial.

Shearwood McClelland,Tim Lautenschlaeger,Kevin Shiue,Amy Miller,Yong Zang,Kathryn I Lauer,Nasser H. Hanna,R.M. Rhome,Namita Agrawal,Paul Anthony,Mu Shan,Jerry J. Jaboin,Gordon A. Watson

Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): Early results from a multicenter phase I trial.

2021

Shearwood McClelland
Tim Lautenschlaeger
Kevin Shiue
Amy Miller
Yong Zang
Kathryn I Lauer
Nasser H. Hanna
R.M. Rhome
Namita Agrawal
Paul Anthony
Mu Shan
Jerry J. Jaboin
Gordon A. Watson

2025Background: The rate of symptomatic radiation necrosis in patients treated with immune checkpoint inhibitor (ICI) therapy and concomitant single-fraction stereotactic radiosurgery (SRS) is as h...

Keywords:

Internal medicine
Medicine
Oncology
Radiation necrosis
in patient
early results
dose reduction
Radiosurgery
Immunotherapy
Concomitant
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations